Biogen

Biogen is a pioneering biotechnology company dedicated to the discovery, development, and delivery of innovative therapies for neurological and neurodegenerative disorders. The enterprise manufactures standard-of-care treatments for multiple sclerosis, spinal muscular atrophy through Spinraza, and Alzheimer’s disease therapies including Leqembi. Through neurobiology research and clinical development, Biogen works to defeat debilitating neurological conditions and improve patient lives.